NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Wipro Ltd Faces Annual Revenue Dent

Wipro Ltd, a leading Bengaluru-based technology services company, is set to incur an estimated annual revenue loss of up to $100 million. The loss is attributed to Estée Lauder, a prominent American cosmetics brand, which has redirected a significant portion of its work under a $500 million, five-year contract to Accenture Plc.

According to reports, the shift in work allocation will have a substantial impact on Wipro's revenue, resulting in a significant annual dent. While the exact financial implications are yet to be disclosed, industry analysts expect Wipro to take a hit due to the loss of this major client. The development is a setback for Wipro, which has been actively pursuing large-scale contracts to drive growth and expansion.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors should be cautious of potential losses for Wipro Ltd due to the loss of a major contract.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.